Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

aspirin-omeprazole

aspirin-omeprazole
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Yosprala DELAYED RELEASE TABLET, ORAL 81 mg-40 mg, 325 mg-40 mg    
Comments:
Ordered Formulation Therapeutic Interchange

aspirin-omeprazole (Yosprala)

  • 81 mg-40 mg delayed release tablet oral
  • 325 mg-40 mg delayed release tablet oral

aspirin AND pantoprazole (Protonix)

  • ONE 81 mg aspirin Enteric delayed release tablet PLUS ONE 40 mg pantoprazole DRT 
  • ONE 325 mg aspirin Enteric delayed release tablet PLUS ONE 40 mg pantoprazole DRT 

If ordered no sub:

aspirin AND omeprazole (PriLOSEC)

  • ONE 81 mg aspirin Enteric delayed release tablet PLUS ONE 40 mg omeprazole DRT 
  • ONE 325 mg aspirin Enteric delayed release tablet PLUS ONE 40 mg omeprazole DRT 

Yosprala medication guide

Reviewed: 23 May 2017 (Yosprala)

Last updated: Jan. 10, 2018






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved